|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES | |||||
| Net income (loss) for the year | |||||
| Adjustments to reconcile net income to net cash flows provided by operating activities | |||||
| Allowances deducted from assets | |||||
| Depreciation of PP&E | |||||
| Amortization of intangible assets | |||||
| Amortization of rights of use assets | |||||
| Depreciation of Investment properties | |||||
| Impairment of goodwill | |||||
| Disposals of Fixed and intangible assets | |||||
| Earnings (losses) from associates and joint ventures | |||||
| Losses from associates and joint ventures | |||||
| Financial results and others | |||||
| Income tax expenses | |||||
| Income tax paid | |||||
| Net increase in assets | |||||
| Net increase in liabilities | |||||
| Change in operating assets and liabilities, net of effects from purchase of controlled entity | |||||
| Increase Trade receivables | |||||
| Decrease / (Increase) Other receivables | |||||
| Decrease / (Increase) Inventories | |||||
| (Decrease) / Increase Trade payables | |||||
| Increase Salaries and social security payables | |||||
| (Decrease) / Increase Other taxes payables | |||||
| (Decrease) / Increase Other Liabilities and Provisions | |||||
| Total cash flows from operating activities | |||||
| CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES | |||||
| Payments for PP&E | |||||
| Payments for intangible asset acquisitions | |||||
| Payments for acquisition of subsidiary and joint venture, net of cash acquired | |||||
| Acquisition of call options agreements | |||||
| Dividends received from associates | |||||
| Proceeds from the sale of PP&E and intangible assets | |||||
| Net investments acquisitions not considered as cash and cash equivalents | |||||
| Payments for acquisition of subsidiary, net of cash acquired | |||||
| Integration of contributions in joint ventures | |||||
| Compensation received for acquisition of companies | |||||
| Proceeds from DFI liquidations | |||||
| Proceeds from sale of investments not considered as cash and cash equivalents | |||||
| Payments for investments not considered as cash and cash equivalents | |||||
| Acquisition of purchase option | |||||
| Total cash flows used in investing activities | |||||
| CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES | |||||
| Proceeds from borrowings | |||||
| Payment of borrowings | |||||
| Payment of interests and related expenses | |||||
| Repurchase of Notes | |||||
| Payment of interests, DFI and related expenses | |||||
| Payments of leases liabilities | |||||
| Transaction with non-controlling interests | |||||
| Dividends paid to non-controlling interests in subsidiaries | |||||
| Total cash flows from (used in) financing activities | |||||
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR | |||||
| NET FOREIGN EXCHANGE DIFFERENCES AND RECPAM ON CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR | |||||
Loading...